CARDIOPROTECTIVE EFFECTS OF LIDOFLAZINE DURING 1-HOUR NORMOTHERMIC GLOBAL-ISCHEMIA

被引：84

作者：

FLAMENG, W ^{[1
]}

DAENEN, W ^{[1
]}

BORGERS, M ^{[1
]}

THONE, F ^{[1
]}

XHONNEUX, R ^{[1
]}

VANDEWATER, A ^{[1
]}

VANBELLE, H ^{[1
]}

机构：

[1] JANSSEN PHARM, RES LABS, B-2340 BEERSE, BELGIUM

来源：

关键词：

D O I：

10.1161/01.CIR.64.4.796

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：796 / 807

页数：12

共 27 条

[1] BLOEM T J J M, 1979, Clinical Cardiology, V2, P407
[2] BORGERS M, 1977, LAB INVEST, V37, P1
[3] BORGERS M, ACTA HISTOCHEM
[4] NIFEDIPINE - MYOCARDIAL PROTECTIVE AGENT
CLARK, RE
CHRISTLIEB, IY
HENRY, PD
FISCHER, AE
NORA, JD
WILLIAMSON, JR
SOBEL, BE
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (05) : 825 - 831
[5] DANIEL WW, 1978, BIOSTATISTICS F ANAL
[6] FERGUSON R J, 1979, Clinical Cardiology, V2, P413
[7] GANOTE CE, 1975, AM J PATHOL, V80, P419
[8] GOBEL FA, 1975, HAMBURG INT LIDOFLAZ
[9] OXYGEN PARADOX AND CALCIUM PARADOX - 2 FACETS OF SAME PROBLEM
HEARSE, DJ
HUMPHREY, SM
BULLOCK, GR
[J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1978, 10 (07) : 641 - 668
[10] HEARSE DJ, 1979, ENZYMES CARDIOLOGY D, P417